Published in Br J Pharmacol on December 01, 1972
Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. Br J Pharmacol (1975) 3.76
Separation of adrenergic and non-adrenergic contractions to field stimulation in the rat vas deferens. Br J Pharmacol (1983) 1.79
The distribution of adrenoceptors and other drug receptors between the two ends of the rat vas deferens as revealed by selective agonists and antagonists. Br J Pharmacol (1980) 1.30
The effects of morphine on the release of noradrenaline from the mouse vas deferens. Br J Pharmacol (1976) 1.27
Rat vas deferens: a specific bioassay for endogenous opioid peptides. Br J Pharmacol (1978) 1.24
An inhibitory role for noradrenaline in the mouse vas deferens. Br J Pharmacol (1977) 1.18
Depression by morphine of excitatory junction potentials in the vas deferens of the mouse. Br J Pharmacol (1976) 1.14
Proceedings: Assessment of the agonist and antagonist activities of narcotic analgesic drugs by means of the mouse vas deferens. Br J Pharmacol (1974) 1.10
An electrophysiological analysis of the effects of reserpine on adrenergic neuromuscular transmission. Br J Pharmacol (1975) 1.09
Action of morphine on the neuro-effector transmission in the guinea-pig ileum and in the mouse vas deferens. J Physiol (1980) 1.07
An electrophysiological analysis of the effects of morphine on the calcium dependence of neuromuscular transmission in the mouse vas deferens. Br J Pharmacol (1980) 1.06
Acetalins: opioid receptor antagonists determined through the use of synthetic peptide combinatorial libraries. Proc Natl Acad Sci U S A (1993) 1.03
The effect of chronic morphine treatment of excitatory junction potentials in the mouse vas deferens. Br J Pharmacol (1980) 1.01
Modulation of (3)H-noradrenaline release by presynaptic opioid, cannabinoid and bradykinin receptors and beta-adrenoceptors in mouse tissues. Br J Pharmacol (2000) 1.00
An electrophysiological study of presynaptic alpha-adrenoceptors in the vas deferens of the mouse. Br J Pharmacol (1983) 0.99
Animal and molecular pharmacology of mixed agonist-antagonist analgesic drugs. Br J Clin Pharmacol (1979) 0.99
Opiate antagonistic properties of an octapeptide somatostatin analog. Proc Natl Acad Sci U S A (1982) 0.98
The effects of morphine on the release of noradrenaline from the cat isolated nictitating membrane and the guinea-pig ileum myenteric plexus-longitudinal muscle preparation. Br J Pharmacol (1975) 0.98
ICI 204448: a kappa-opioid agonist with limited access to the CNS. Br J Pharmacol (1989) 0.97
Design of novel neurokinin 1 receptor antagonists based on conformationally constrained aromatic amino acids and discovery of a potent chimeric opioid agonist-neurokinin 1 receptor antagonist. J Med Chem (2011) 0.94
Cyclic opioid peptide agonists and antagonists obtained via ring-closing metathesis. Chem Biol Drug Des (2009) 0.92
Dicarba analogues of the cyclic enkephalin peptides H-Tyr-c[D-Cys-Gly-Phe-D(or L)-Cys]NH(2) retain high opioid activity. J Med Chem (2007) 0.92
The dependence of excitatory junction potential amplitude on the external calcium concentration in narcotic tolerant mouse vas deferens. Br J Pharmacol (1984) 0.90
Proposal for the biologically active conformation of opiates and enkephalin. Proc Natl Acad Sci U S A (1977) 0.90
The effects of 4-aminopyridine on the isolated vas deferens and its effects on the inhibitory properties of adenosine, morphine, noradrenaline and gamma-aminobutyric acid. Br J Pharmacol (1981) 0.88
Blockade of pre-synaptic alpha-adrenoceptors by metiamide [proceedings]. Br J Pharmacol (1978) 0.88
N-methylated cyclic enkephalin analogues retain high opioid receptor binding affinity. Chem Biol Drug Des (2009) 0.88
Inhibition of neuroeffector transmission by morphine in the vas deferens of naive and morphine-treated mice. Br J Pharmacol (1980) 0.87
Interactions among the effects of normorphine, calcium and magnesium on transmitter release in the mouse vas deferens. Br J Pharmacol (1982) 0.85
Variation of the net charge, lipophilicity, and side chain flexibility in Dmt(1)-DALDA: Effect on Opioid Activity and Biodistribution. J Med Chem (2012) 0.85
Effects of endorphins on different parts of the gastrointestinal tract of rat and guinea-pig in vitro. Br J Pharmacol (1980) 0.84
Clonidine and morphine increase [3H]-noradrenaline overflow in mouse vas deferens. Br J Pharmacol (1988) 0.84
Enkephalin receptor in the rabbit ileum. Br J Pharmacol (1980) 0.84
Effects of narcotic analgesics and their antagonists on the rabbit isolated heart and its adrenergic nerves. Br J Pharmacol (1973) 0.83
"Carba"-analogues of fentanyl are opioid receptor agonists. J Med Chem (2010) 0.83
Plasma native and peptidase-derivable Met-enkephalin responses to restraint stress in rats. Adaptation to repeated restraint. J Clin Invest (1990) 0.82
[Dmt(1)]DALDA analogues with enhanced μ opioid agonist potency and with a mixed μ/κ opioid activity profile. Bioorg Med Chem (2014) 0.82
Effects of morphine on electrically evoked contractions of the vas deferens in two congeneric rodent species differing in sperm competition intensity. Proc Biol Sci (1999) 0.81
Morphine depression and tolerance of nerve-induced parotid secretion. Br J Pharmacol (1979) 0.81
Presynaptic opioid delta-receptors in the rabbit mesenteric artery. J Physiol (1986) 0.81
Effects of divalent cations and normorphine on spontaneous excitatory junction potentials in the mouse vas deferens. Br J Pharmacol (1982) 0.80
The effects of morphine and methionine-enkephalin on the release of purines from cerebral cortex slices of rats and mice. Br J Pharmacol (1981) 0.80
Effect of chronic morphine treatment on alpha(2)-adrenoceptor mediated autoinhibition of transmitter release from sympathetic varicosities of the mouse vas deferens. Br J Pharmacol (2001) 0.80
Theophylline does not affect morphine inhibition of the isolated vas deferens. Br J Pharmacol (1981) 0.78
Pharmacological differentiation of presynaptic inhibitory alpha-adrenoceptors and opiate receptors in the cat nictitating membrane. Br J Pharmacol (1980) 0.77
Effect of opioid receptor subtype-selective agonists on purinergic and adrenergic components of neurogenic contractions of mouse vas deferens. Br J Pharmacol (1993) 0.77
Parasympathetic depression of vas deferens contraction in the guinea-pig involves adenosine receptors. J Physiol (1988) 0.77
A study of the role of cyclic adenosine 3',5'-monophosphate in the depression by opiates and opioid peptides of excitatory junction potentials in the mouse vas deferens. Br J Pharmacol (1980) 0.75
Micturition in naive and morphine-dependent rats. Br J Pharmacol (1986) 0.75
Pre-synaptic alpha-adrenoceptors and the inhibition by uptake blocking agents of the twitch response of the mouse vas deferens [proceedings]. Br J Pharmacol (1977) 0.75
Enkephalin-like immunoreactivity in the human male genital tract. J Anat (1982) 0.75
A Cyclic Tetrapeptide ("Cyclodal") and Its Mirror-Image Isomer Are Both High-Affinity μ Opioid Receptor Antagonists. J Med Chem (2016) 0.75
Cyclic enkephalin-deltorphin hybrids containing a carbonyl bridge: structure and opioid activity. Acta Biochim Pol (2011) 0.75
An examination of the putative sigma-receptor in the mouse isolated vas deferens. Br J Pharmacol (1989) 0.75
Bifunctional μ/δ opioid peptides: variation of the type and length of the linker connecting the two components. Chem Biol Drug Des (2012) 0.75
[Dmt(1)]DALDA analogues modified with tyrosine analogues at position 1. Bioorg Med Chem Lett (2016) 0.75
Sensitivity of mouse vas deferens to neurotransmitters: changes after morphine treatment. Br J Pharmacol (1979) 0.75
Proceedings of the British Pharmacological Society. Cambridge, 8th-10th April 1987. Abstracts. Br J Pharmacol (1987) 0.75
'Carba'-carfentanil (trans isomer): a μ opioid receptor (MOR) partial agonist with a distinct binding mode. Bioorg Med Chem (2014) 0.75
Opiate tolerance and cross-tolerance in the mouse vas deferens [proceedings]. Br J Pharmacol (1979) 0.75
Effect of opiates on transmitter release from visualized hypogastric boutons innervating the rat pelvic ganglia. Br J Pharmacol (1996) 0.75
Analgesic properties of opioid/NK1 multitarget ligands with distinct in vitro profiles in naive and chronic constriction injury (CCI)-mice. ACS Chem Neurosci (2017) 0.75
Opioid receptor characterisation of neuronally stimulated isolated human vas deferens. Naunyn Schmiedebergs Arch Pharmacol (2012) 0.75
The action of morphine and related substances on contraction and on acetylcholine output of coaxially stimulated guinea-pig ileum. Br J Pharmacol Chemother (1957) 13.02
Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Br J Pharmacol (1972) 4.45
The action of morphine on the superior cervical ganglion and on the nictitating membrane of the cat. Br J Pharmacol Chemother (1957) 3.36
Effect of morphine on some sympathetically innervated effectors. Br J Pharmacol Chemother (1961) 2.73
3 H-noradrenaline release and mechanical response in the field stimulated mouse vas deferens. Acta Physiol Scand Suppl (1971) 2.52
The effects of hexamethonium, morphine and adrenaline on the output of acetylcholine from the myenteric plexus-longitudinal muscle preparation of the ileum. Br J Pharmacol (1970) 2.43
Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA (2000) 10.40
Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature (1975) 10.33
Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A (2006) 10.24
Passive smoking and the risk of coronary heart disease--a meta-analysis of epidemiologic studies. N Engl J Med (1999) 9.26
Endogenous opioid peptides: multiple agonists and receptors. Nature (1977) 8.21
Clinical and epidemiologic features of primary HIV infection. Ann Intern Med (1996) 6.04
Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection. N Engl J Med (1997) 5.72
Comorbidities, complications, and coding bias. Does the number of diagnosis codes matter in predicting in-hospital mortality? JAMA (1992) 5.07
Kinetic parameters of narcotic agonists and antagonists, with particular reference to N-allylnoroxymorphone (naloxone). Br J Pharmacol Chemother (1968) 5.00
Harnessing peer networks as an instrument for AIDS prevention: results from a peer-driven intervention. Public Health Rep (1998) 4.85
The gene for familial polyposis coli maps to the long arm of chromosome 5. Science (1987) 4.48
Evaluation of mechanisms controlling the release and inactivation of the adrenergic transmitter in the rabbit portal vein and vas deferens. Br J Pharmacol (1972) 4.45
Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension (2001) 4.41
The effects of adrenaline, noradrenaline and isoprenaline on inhibitory alpha- and beta-adrenoceptors in the longitudinal muscle of the guinea-pig ileum. Br J Pharmacol (1970) 4.22
Homology between P-glycoprotein and a bacterial haemolysin transport protein suggests a model for multidrug resistance. Nature (1987) 3.79
Effect of morphine on adrenergic transmission in the mouse vas deferens. Assessment of agonist and antogonist potencies of narcotic analgesics. Br J Pharmacol (1975) 3.76
The use of an optical brightener in the study of plant structure. Stain Technol (1975) 3.70
Virus-induced neuronal apoptosis blocked by the herpes simplex virus latency-associated transcript. Science (2000) 3.51
Mutational analysis of the adeno-associated virus type 2 (AAV2) capsid gene and construction of AAV2 vectors with altered tropism. J Virol (2000) 3.27
Isolation of an endogenous compound from the brain with pharmacological properties similar to morphine. Brain Res (1975) 3.26
Head and neck schwannomas--a 10 year review. J Laryngol Otol (2000) 3.25
The effects of changes in dietary protein on the composition and structure of the liver cell. J Physiol (1947) 3.07
Mode of action of morphine-like drugs on autonomic neuro-effectors. Nature (1968) 3.01
Chronic conditions and risk of in-hospital death. Health Serv Res (1994) 3.00
Detection of abnormal memory decline in mild cases of Alzheimer's disease using CERAD neuropsychological measures. Arch Neurol (1991) 2.89
Using conjoint analysis to assess women's preferences for miscarriage management. Health Econ (1997) 2.87
Agonist and antagonist actions of morphine-like drugs on the guinea-pig isolated ileum. Br J Pharmacol Chemother (1966) 2.67
The distribution of methionine-enkephalin and leucine-enkephalin in the brain and peripheral tissues. Br J Pharmacol (1977) 2.59
In vitro models in the study of structure-activity relationships of narcotic analgesics. Annu Rev Pharmacol (1975) 2.47
The effects of hexamethonium, morphine and adrenaline on the output of acetylcholine from the myenteric plexus-longitudinal muscle preparation of the ileum. Br J Pharmacol (1970) 2.43
Inhibition of isoleucyl-transfer ribonucleic acid synthetase in Escherichia coli by pseudomonic acid. Biochem J (1978) 2.41
Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome. Nat Genet (1994) 2.35
Low muscle mass and sarcopenia: common and predictive of osteopenia in inflammatory bowel disease. Aliment Pharmacol Ther (2015) 2.34
Use of expiratory CT pulmonary angiography to reduce inspiration and breath-hold associated artefact: contrast dynamics and implications for scan protocol. Clin Radiol (2011) 2.30
Verification of smoking history in patients after infarction using urinary nicotine and cotinine measurements. Br Med J (1979) 2.30
Reactive oxygen species in oncogenic transformation. Biochem Soc Trans (2003) 2.26
Interaction of pseudomonic acid A with Escherichia coli B isoleucyl-tRNA synthetase. Biochem J (1980) 2.24
Errors in using tobacco withdrawal scale. Tob Control (1998) 2.23
Agonist-selective mechanisms of GPCR desensitization. Br J Pharmacol (2007) 2.17
Evidence that angiotensin enhances transmitter release during sympathetic nerve stimulation. Br J Pharmacol (1971) 2.17
Classification of opioid receptors. Br Med Bull (1983) 2.12
Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes. J Immunol (1999) 2.09
Osteopontin--a molecule for all seasons. QJM (2002) 2.09
Soluble forms of vascular adhesion molecules, E-selectin, ICAM-1, and VCAM-1: pathological significance. Ann N Y Acad Sci (1992) 2.06
Assessment in the guinea-pig ileum and mouse vas deferens of benzomorphans which have strong antinociceptive activity but do not substitute for morphine in the dependent monkey. Br J Pharmacol (1975) 2.05
A randomised controlled trial of the effect of the provision of free school milk on the growth of children. J Epidemiol Community Health (1980) 2.04
The phototropin family of photoreceptors. Plant Cell (2001) 2.01
The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.99
Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol (2001) 1.98
A review of the epidemiological evidence for the 'antioxidant hypothesis'. Public Health Nutr (2004) 1.97
Spectrum of the mu, delta- and kappa-binding sites in homogenates of rat brain. Br J Pharmacol (1982) 1.91
A prokaryotic phytochrome. Nature (1997) 1.91
Formula milk versus donor breast milk for feeding preterm or low birth weight infants. Cochrane Database Syst Rev (2007) 1.91
Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol (2001) 1.90
Stable transgene expression in rod photoreceptors after recombinant adeno-associated virus-mediated gene transfer to monkey retina. Proc Natl Acad Sci U S A (1999) 1.89
beta 3: an additional auxiliary subunit of the voltage-sensitive sodium channel that modulates channel gating with distinct kinetics. Proc Natl Acad Sci U S A (2000) 1.89
Purification and properties of enkephalin - the possible endogenous ligand for the morphine receptor. Life Sci (1975) 1.88
An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART. AIDS Care (2005) 1.87
Influence of dose and fiber type on respiratory malignancy risk in asbestos cement manufacturing. Am Rev Respir Dis (1979) 1.85
Quasi morphine-abstinence syndrome. Nature (1974) 1.85
Value of routine chest radiography of psychiatric patients. Br Med J (1980) 1.84
Mesangial cell apoptosis: the major mechanism for resolution of glomerular hypercellularity in experimental mesangial proliferative nephritis. J Clin Invest (1994) 1.83
Gabapentin (neurontin) and S-(+)-3-isobutylgaba represent a novel class of selective antihyperalgesic agents. Br J Pharmacol (1997) 1.82
Characterization of the kappa-subtype of the opiate receptor in the guinea-pig brain. Br J Pharmacol (1981) 1.80
Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol (1998) 1.79
Incorporation of labelled amino acids into the enkephalins. FEBS Lett (1977) 1.73
Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy. Kidney Int (2000) 1.72
Some thoughts on the significance of enkephalin, the endogenous ligand. Life Sci (1975) 1.71
Placental-specific insulin-like growth factor 2 (Igf2) regulates the diffusional exchange characteristics of the mouse placenta. Proc Natl Acad Sci U S A (2004) 1.69
On the mode of action of pseudomonic acid: inhibition of protein synthesis in Staphylococcus aureus. J Antibiot (Tokyo) (1978) 1.67
Acceleration of noradrenaline biosynthesis in the guinea-pig vas deferens by potassium. Br J Pharmacol (1970) 1.64
The physical maps for sequencing human chromosomes 1, 6, 9, 10, 13, 20 and X. Nature (2001) 1.63
Methicillin-resistant Staphylococcus aureus in children with cystic fibrosis: An eradication protocol. Pediatr Pulmonol (2003) 1.61
Resting and action potentials recorded by the sucrose-gap method in the superior cervical ganglion of the rabbit. J Physiol (1968) 1.61
Characterization of alpha 2-adrenoceptors which increase potassium conductance in rat locus coeruleus neurones. Neuroscience (1985) 1.60
Obstructive uropathy in the mouse: role of osteopontin in interstitial fibrosis and apoptosis. Kidney Int (1999) 1.60
Characterization of recombinant phytochrome from the cyanobacterium Synechocystis. Proc Natl Acad Sci U S A (1997) 1.60
Intensive care-management at home: an alternative to institutional care? Age Ageing (2001) 1.58
Lead exposure in a firing range. Am J Public Health (1987) 1.58
Comparison of the binding characteristics of tritiated opiates and opioid peptides. Br J Pharmacol (1980) 1.56
In vitro pharmacology of the opioid peptides, enkephalins and endorphins. Eur J Pharmacol (1977) 1.56
Inhibition of noradrenaline release by lysergic acid diethylamide. Br J Pharmacol (1973) 1.56
Region of herpes simplex virus type 1 latency-associated transcript sufficient for wild-type spontaneous reactivation promotes cell survival in tissue culture. J Virol (2001) 1.55
A systematic literature review of the effectiveness of non-pharmacological interventions to prevent wandering in dementia and evaluation of the ethical implications and acceptability of their use. Health Technol Assess (2006) 1.53
Older Medicare enrolees' choices for insured services. J Am Geriatr Soc (1997) 1.53
Characterization of opioid receptors in nervous tissue. Proc R Soc Lond B Biol Sci (1980) 1.52
Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease. Am J Kidney Dis (2001) 1.52
Lipid infusion in the management of poisoning: a report of 6 canine cases. Vet Rec (2013) 1.51
Estimating the efficacy of interventions to prevent mother-to-child transmission of HIV in breast-feeding populations: development of a consensus methodology. Stat Med (2001) 1.50
Noradrenaline-mediated synaptic inhibition in rat locus coeruleus neurones. J Physiol (1983) 1.49
SnR30: a new, essential small nuclear RNA from Saccharomyces cerevisiae. Nucleic Acids Res (1988) 1.48